salmeterol xinafoate has been researched along with alpha 1-Antitrypsin Deficiency in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertella, E; Boni, E; Corda, L; La Piana, GE; Redolfi, S; Tantucci, C | 1 |
1 trial(s) available for salmeterol xinafoate and alpha 1-Antitrypsin Deficiency
Article | Year |
---|---|
Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
Topics: Administration, Inhalation; Aged; Albuterol; alpha 1-Antitrypsin Deficiency; Beclomethasone; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Dyspnea; Exercise Tolerance; Female; Glucocorticoids; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Salmeterol Xinafoate; Scopolamine Derivatives | 2008 |